Organic Compounds
AssigneeNabriva Therapeutics Forschungs GmbH
InventorsRosemarie Mang, Heinz Berner
Life of this patent
Estimating the term…
Loading patent…
AssigneeNabriva Therapeutics Forschungs GmbH
InventorsRosemarie Mang, Heinz Berner
Estimating the term…
The present invention relates to compounds selected from the group consisting of 14-0-[((Mono- or dialkylamino)-cycloalkylsulfanyl- or -cycloalkyl-oxy)-acetyl, -thioacetyl or -imino-oxy]-mutilins, 14-O-[((Cycloalkyl- or heterocyclylamino)-cy-cloalkylsulfanyl- or -cycloalkyl-oxy)-acetyl, -thioaceyl or -imino-oxy]-mutilins, 14-O-[((Heterocyc-N-yl-cycloalkyl)-sulfanyl- or -oxy)-acetyl, -thioacetyl or -imino-oxy]-mutilins, 14-O-[(((Mono- or dialkylamino)-cycloalkyl)-alkylsulfanyl- or -alkyl-oxy)-acetyl, -thioacetyl or -imino-oxy]-mutilins, 14-O-[(((Cycloalkyl- or heterocyclylamino)-cycloalkyl)-alkylsulfanyl- or -alkyl-oxy)-acetyl, -thioacetyl or -imino-oxy]-mutilins, and 14-O-[((Heterocyc-N-yl-cycloalkyl)-alkylsulfanyl- or -alkyl-oxy)-acetyl, -thioacetyl or -imino-oxy]-mutilins, and their use as pharmaceuticals.
1-14. (canceled)
A compound comprising:
A method of treatment of diseases mediated by microbes which comprises:
A method of preparing a medicament for the treatment of diseases mediated by microbes, said method comprising:
A pharmaceutical composition comprising:
Dependencies are inferred from the claim text.